Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Market Analysis & Valuation

UpdatedJun 29, 2026
DataAggregated Company Financials
Companies1085
  • 7D1.1%
  • 3M4.0%
  • 1Y18.0%
  • YTD5.2%

Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 5.9% in that time. More promisingly, the market is up 18% over the past year. Looking forward, earnings are forecast to grow by 11% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.K. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 Jun 2026UK£2.9tUK£2.0tUK£165.2b15.6x17.8x1.4x
Thu, 28 May 2026UK£3.0tUK£2.0tUK£164.7b16x18x1.5x
Sat, 25 Apr 2026UK£2.9tUK£2.0tUK£157.4b16x18.6x1.5x
Mon, 23 Mar 2026UK£2.8tUK£2.0tUK£156.8b14.8x17.8x1.4x
Wed, 18 Feb 2026UK£3.0tUK£1.9tUK£146.1b16.6x20.7x1.6x
Fri, 16 Jan 2026UK£2.9tUK£2.0tUK£138.2b16.7x21.2x1.5x
Sun, 14 Dec 2025UK£2.8tUK£2.0tUK£138.2b15.9x20x1.4x
Tue, 11 Nov 2025UK£2.8tUK£2.0tUK£138.1b16.4x20.3x1.4x
Thu, 09 Oct 2025UK£2.7tUK£1.9tUK£135.6b16.8x20.3x1.4x
Sat, 06 Sep 2025UK£2.7tUK£1.9tUK£135.6b16.4x19.7x1.4x
Mon, 04 Aug 2025UK£2.6tUK£2.0tUK£134.5b16.3x19.5x1.3x
Wed, 02 Jul 2025UK£2.5tUK£1.9tUK£126.6b16.4x19.6x1.3x
Fri, 30 May 2025UK£2.5tUK£1.9tUK£127.3b16.1x19.4x1.3x
Sun, 27 Apr 2025UK£2.4tUK£2.0tUK£134.9b15.3x17.7x1.2x
Tue, 25 Mar 2025UK£2.5tUK£2.0tUK£136.0b15.6x18.1x1.2x
Thu, 20 Feb 2025UK£2.5tUK£2.0tUK£139.1b16.5x18.2x1.3x
Sat, 18 Jan 2025UK£2.5tUK£2.1tUK£125.0b16x19.9x1.2x
Mon, 16 Dec 2024UK£2.4tUK£2.0tUK£122.5b16.3x19.9x1.2x
Wed, 13 Nov 2024UK£2.4tUK£2.0tUK£119.1b16.3x19.9x1.2x
Fri, 11 Oct 2024UK£2.4tUK£2.0tUK£118.9b16.3x20.2x1.2x
Sun, 08 Sep 2024UK£2.4tUK£2.0tUK£119.2b16.7x20.2x1.2x
Tue, 06 Aug 2024UK£2.4tUK£2.0tUK£125.3b16.2x18.8x1.2x
Thu, 04 Jul 2024UK£2.4tUK£2.0tUK£131.0b16.7x18.4x1.2x
Sat, 01 Jun 2024UK£2.5tUK£2.0tUK£129.3b17.3x19.1x1.2x
Mon, 29 Apr 2024UK£2.4tUK£2.1tUK£143.7b16x16.9x1.2x
Wed, 27 Mar 2024UK£2.4tUK£2.1tUK£146.3b16.3x16.4x1.1x
Fri, 23 Feb 2024UK£2.3tUK£2.0tUK£143.2b15.4x16.1x1.1x
Sun, 21 Jan 2024UK£2.3tUK£2.1tUK£193.6b14.6x11.7x1.1x
Tue, 19 Dec 2023UK£2.3tUK£2.1tUK£194.1b14.9x11.8x1.1x
Thu, 16 Nov 2023UK£2.3tUK£2.1tUK£193.7b14.3x11.7x1.1x
Sat, 14 Oct 2023UK£2.3tUK£2.2tUK£187.0b13.8x12.4x1.1x
Mon, 11 Sep 2023UK£2.3tUK£2.2tUK£185.6b14.5x12.4x1.1x
Wed, 09 Aug 2023UK£2.3tUK£2.2tUK£189.4b14.4x12.3x1.1x
Fri, 07 Jul 2023UK£2.3tUK£2.2tUK£208.2b13.9x10.9x1x
Price to Earnings Ratio

10.9x


Total Market Cap: UK£2.3tTotal Earnings: UK£208.2bTotal Revenue: UK£2.2tTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Market Price to Earnings3Y Average 17.6x202420252026
Current Market PE
  • Investors are relatively neutral on the British market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading close to its 3-year average PE ratio of 17.6x.
Past Earnings Growth
  • The earnings for companies in the British industry have declined 7.4% per year over the last three years.
  • Revenues have also declined 2.3% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Sector Trends

Which sectors have driven the changes within the U.K. Market?

GB Market0.17%
Healthcare5.87%
Real Estate5.85%
Consumer Staples4.66%
Utilities2.70%
Consumer Discretionary1.73%
Industrials0.027%
Telecom-0.80%
Financials-0.81%
Tech-1.93%
Energy-4.22%
Materials-6.47%
Sector PE
  • Investors favour the Telecom sector the most for future growth which is trading above its 3-year average PE ratio.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 25.8%, which is higher than its past year's earnings growth of 3.1% per year.
  • The Financials sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 10.2x.
Forecasted Growth
  • Analysts are most optimistic on the Telecom sector, expecting annual earnings growth of 26% over the next 5 years.
  • This is better than its past earnings growth rate of 3.1% per year.
  • In contrast, the Consumer Staples sector is expected to see its earnings grow by 6.9% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
AZN AstraZenecaUK£142.987.6%
+UK£15.6b		41.3%PE28.3xHealthcare
BATS British American TobaccoUK£47.176.1%
+UK£5.9b		36.2%PE13.3xConsumer Staples
ULVR UnileverUK£45.804.3%
+UK£4.1b		-8.0%PE20.2xConsumer Staples
III 3i GroupUK£24.9610.5%
+UK£2.4b		-39.4%PE4.8xFinancials
GSK GSKUK£19.802.9%
+UK£2.2b		42.4%PE13.5xHealthcare
See more

Market Insights

Header cover image
Yield measures a moment. A decade of raising it measures the business: durable earnings, a clean balance sheet, and management disciplined enough to keep it.
Continue reading
Watt's left in the overcrowded power trade?

Latest News

AZN
UK£142.98
AstraZeneca
7D
7.6%
1Y
41.3%
BATS
UK£47.17
British American Tobacco
7D
6.1%
1Y
36.2%
RIO
UK£70.76
Rio Tinto Group
7D
-5.8%
1Y
66.7%
ULVR
UK£45.80
Unilever
7D
4.3%
1Y
-8.0%
SHEL
UK£29.01
Shell
7D
-3.6%
1Y
13.6%
HSBA
UK£14.24
HSBC Holdings
7D
-1.9%
1Y
61.5%
III
UK£24.96
3i Group
7D
10.5%
1Y
-39.4%
Narrative Update • Jun 26

III: Share Buyback And Dividend Framework Will Support Future Upside Potential

The latest Narrative Update on 3i Group reflects a lower analyst price target, with one key firm cutting its view from £43.00 to £35.27 per share. Analysts are factoring in a revised fair value of £43.00, an 8.16% discount rate, updated revenue growth of 21.54%, a profit margin of 70.31% and a future P/E of 8.63.
GSK
UK£19.80
GSK
7D
2.9%
1Y
42.4%
SGRO
UK£8.78
SEGRO
7D
18.0%
1Y
29.2%
RKT
UK£49.42
Reckitt Benckiser Group
7D
6.9%
1Y
-4.3%
Narrative Update • Jun 24

RKT: Future Returns Will Rely On Resilient Margins And Share Repurchases

Reckitt Benckiser Group’s analyst fair value estimate has edged down slightly, in line with a series of recent price target trims that include Morgan Stanley’s move from £62.00 to £58.00 and Citi’s £8.00 reduction, as analysts reassess assumptions while broadly maintaining a constructive stance on the stock. Analyst Commentary Recent research on Reckitt Benckiser Group has centered on adjustments to price targets and ratings, giving you a clearer picture of how the Street is weighing valuation support against execution risks.
NG.
UK£12.55
National Grid
7D
2.7%
1Y
18.2%
BP.
UK£4.73
BP
7D
-5.5%
1Y
29.3%
ANTO
UK£37.47
Antofagasta
7D
-5.3%
1Y
107.1%
Narrative Update • Jun 23

ANTO: Rising Execution Risks Will Likely Cap Copper Upside Potential

Antofagasta's updated fair value estimate has risen from £23.50 to £26.50 per share. This reflects analysts' higher price targets and assumptions for stronger top line growth, offset by slightly lower profit margins and a higher future P/E multiple.
GLEN
UK£5.11
Glencore
7D
-8.6%
1Y
80.2%
New Narrative • Jun 19

Copper Expansion And Political Risks Will Reshape Long Term Earnings Profile

Catalysts About Glencore Glencore is a diversified natural resources group involved in mining, processing and marketing of metals, energy products and other commodities. What are the underlying business or industry changes driving this perspective?
AAL
UK£36.27
Anglo American
7D
-7.1%
1Y
68.7%
Narrative Update • Jun 16

AAL: Copper Shift And Iron Ore Risks Will Shape Fairly Balanced Outlook

Anglo American's fair value estimate has moved from £36.80 to £38.39 as analysts adjust price targets higher by several hundred pence and highlight a shift in growth focus toward copper over iron ore, while also reflecting updated assumptions for revenue growth, profit margins and future P/E. Analyst Commentary Recent research on Anglo American highlights a split view, with several bullish analysts lifting price targets while more cautious voices flag earnings pressure in iron ore and execution risks around the shift toward copper.
FRES
UK£27.81
Fresnillo
7D
-7.5%
1Y
93.1%
Narrative Update • Jun 16

FRES: Higher Revenue Assumptions And Cost Discipline Will Support Re Rating Potential

The analyst price target for Fresnillo has shifted to reflect a modest fair value adjustment to £54.36, as analysts reassessed assumptions for revenue growth, profit margins and future P/E following a series of mixed target changes from Citi, Morgan Stanley, JPMorgan and Berenberg. Analyst Commentary Recent research on Fresnillo highlights a split in opinion, but there are clear areas where bullish analysts see room for the stock to better reflect their reassessed fair value assumptions.